 | Up a level |
Claudiani, Simone, Apperley, Jane F, Gale, Robert Peter, Clark, Richard 
ORCID: 0000-0002-1261-3299, Szydlo, Richard ORCID: 0000-0003-1102-8298, Deplano, Simona, Palanicawandar, Renuka, Khorashad, Jamshid, Foroni, Letizia and Milojkovic, Dragana
(2017)
E14a2 <i>BCR-ABL1</i> transcript is associated with a higher rate of treatment-free remission in individuals with chronic myeloid leukemia after stopping tyrosine kinase inhibitor therapy.
Haematologica, 102 (8).
e297-e299.
Claudiani, Simone, Janssen, Jeroen JWM, Byrne, Jenny, Smith, Graeme, Blijlevens, Nicole, Raghavan, Manoj, Smith, Matthew, Clark, Richard E ORCID: 0000-0002-1261-3299, Mclain-Smith, Susan, Carter, Angela M et al (show 2 more authors)
(2022)
A retrospective observational research study to describe the real-world use of bosutinib in patients with chronic myeloid leukemia in the United Kingdom and the Netherlands.
EUROPEAN JOURNAL OF HAEMATOLOGY, 109 (1).
pp. 90-99.